Compare XCUR & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XCUR | NSYS |
|---|---|---|
| Founded | 2011 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.6M | 25.6M |
| IPO Year | 2017 | 1996 |
| Metric | XCUR | NSYS |
|---|---|---|
| Price | $3.96 | $14.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.1K | ★ 26.6K |
| Earning Date | 03-25-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.37 | 80.85 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $14,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.01 |
| 52 Week Low | $3.10 | $6.50 |
| 52 Week High | $12.65 | $14.45 |
| Indicator | XCUR | NSYS |
|---|---|---|
| Relative Strength Index (RSI) | 45.22 | 76.54 |
| Support Level | $3.51 | $8.40 |
| Resistance Level | $4.23 | N/A |
| Average True Range (ATR) | 0.22 | 0.90 |
| MACD | -0.05 | 0.18 |
| Stochastic Oscillator | 29.10 | 98.91 |
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.